Burning Rock GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings The GenomeWeb Index outperformed the Dow Jones last month, but underperformed the Nasdaq and the Nasdaq Biotechnology Index. Burning Rock Details Plans for Cancer Monitoring Assay, Adds New Data Supporting Early Detection Premium Both the MRD test, BR Prophet, and a six-cancer screening assay, BR Predict, are slated for launch in China next year, initially for contracted hospital customers. Burning Rock Q2 Revenues up 19 Percent The company highlighted growth in its hospital testing business, which increased 47 percent with 34 contracted partner hospitals now on the books. Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib. GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases The GenomeWeb Index outperformed the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index last month. May 26, 2021 Burning Rock Embarks on Large-Scale Study for 22-Cancer Screening Assay Premium May 25, 2021 Burning Rock Q1 Revenues Rise 58 Percent Apr 13, 2021 FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines Premium Apr 1, 2021 GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock Mar 11, 2021 Burning Rock Q4 Revenues Rise 50 Percent Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Jan 4, 2021 GenomeWeb Index Ends 2020 on Upswing With Pacific Biosciences in Lead Dec 16, 2020 Piper Sandler Raises Rating on Oncocyte to Overweight Dec 15, 2020 Burning Rock Biotech Licenses Oncocyte Lung Cancer Assay Nov 20, 2020 Burning Rock Adds New Data Supporting Cancer Screening Liquid Biopsy, Automated NGS Products Premium Nov 20, 2020 Burning Rock Q3 Revenues Up 19 Percent Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.